Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)

Inclusion Criteria: * Subject is a male between the ages of 18 and 45 or a female less than or equal to 70 years of age * Females must be past menopause * Subject is a nonsmoker * Subject is willing to avoid excessive alcohol consumption during the study and is willing to avoid alcohol entirely for 24 hours prior to drug administration and during PK sampling * Subject is willing to refrain from consuming grapefruit or grapefruit juice Exclusion Criteria: * Subject has a history of multiple/severe allergies to drugs or food * Subject has donated blood within 4 weeks of starting the study * Subject has a history of metabolic bone disease, urolithiasis, or bisphosphonate treatment * Subject has any infections or any condition leading to immune problems, including HIV * Subject regularly uses illegal drugs * Subject consumes more than 3 alcoholic beverages per day * Subject drinks 4 or more caffeinated beverages per day * Subject uses any prescription or nonprescription medications